Kalytera Therapeutics (KLY.V) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Kalytera Therapeutics (KLY.V)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.05

-0.00 (0.00%)

as of Apr 9, 2021, 7:54:46 pm Market Open.

19 watching

BUY

Just announced a discovery in Columbia. Flow tested over 2000 barrels per day. This well could produce up to 5000 when brought into production. A very well distributed stock so it might not jump too fast. Company could get taken out.

HOLD

Presently trading at cash value. Drilling up in Colombia right now and the new management team has come in to try to make sure they're not spending too much money too quickly. Will see drill results in the next few weeks.

HOLD

Stock has really lagged. New management. Have about $0.04-$0.05 in cash on the balance sheet. Just waiting for permits to drill in Colombia. Thinks they have some good assets.

HOLD

Drilling in Colombia. Has been an under performer. The big story is that they haven't been able to drill as quickly as they thought they would because of permitting. Until they drill and you find out what they have, hold on to what you have.

BUY

Oil/gas exploration in Colombia. Was weak and bottomed at around $0.10. Did a $35 million fund raising and are fully cashed up. Drilling 5 wells this year beginning in the summer. Prospects are pretty good. (Doesn’t own in his fund but Sprott owns.)

BUY

Colombian oil and gas. Pretty much dead money for the last while. Made a discovery worth between 500 and 1,000 BOE’s so will have quite a bit of cash flow in the next couple of months. Did a large financing for some wells that have very large targets so financing risks are gone.

HOLD

Disappointing result when they had a secondary zone come in on prognosis primary zone didn’t produce what they were hoping for. Will be drilling 5 wells in Colombia this year and 2 in Guatemala. Will have about 500 barrels a day production in about a month.

PAST TOP PICK

(A Top Pick April 30/10. Down 21.62%.) Still Likes.

BUY

Could be results tomorrow. You are still playing slightly for some success. He prefers to get exploration for free. Columbia exposure.

COMMENT

Has done very well. Been increasing on 2 primary themes. 1) Junior Colombian names have been very strong recently and 2) appear to have made an oil discovery where net oil play was significantly more than expected.

RISKY

You are in the zone of testing right now. Have an oil well and put out a press release this week. Until they come out with a number you don’t know. If they hit this well you could see good things.

HOLD

Some hiccups trying to bring a well into production in Guatemala. True upside in this story is in Colombia. Had about 110 feet of net pay in Colombia before having to give back their loaned rig. Bringing another rig in and will be testing in a couple of weeks. Arranged another $9.5 million of financing. Still cheap.

BUY

Still waiting for results from Guatemala. Spudded a well in Colombia that should be giving some news in the next 6 weeks or so. Huge targets. All the companies around them have been hitting 5000-10,000 BOE's and it would be a game changer for them if they could hit any of these. Speculative.

TOP PICK

Gas play in Guatemala and Colombia. Have a lot of land blocks near where Petrominerales (PMG-T) hit. Just drilled a well with a fairly large target in Guatemala and found oil at a much higher area than expected. Cased the well and we'll hear more next week. Highly speculative.

Showing 1 to 14 of 14 entries

Kalytera Therapeutics (KLY.V) Frequently Asked Questions

What is Kalytera Therapeutics stock symbol?

Kalytera Therapeutics is a Canadian stock, trading under the symbol KLY.V (previously KLY-X on Stockchase) on the TSX Venture Exchange (KLY-CV). It is usually referred to as TSXV:KLY or KLY.V

Is Kalytera Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on KLY.V (previously KLY-X on Stockchase) on Stockchase. Read the latest expert commentary for Kalytera Therapeutics.

Is Kalytera Therapeutics a good investment or a top pick?

Kalytera Therapeutics was recommended as a Top Pick by Peter Imhof on 2010-04-30. Read the latest stock experts ratings for Kalytera Therapeutics.

Why is Kalytera Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Kalytera Therapeutics.

Is Kalytera Therapeutics worth watching?

Kalytera Therapeutics is followed by 19 investors on Stockchase and is a trending stock that is worth watching.

What is Kalytera Therapeutics stock price?

On 2021-04-09, Kalytera Therapeutics (KLY.V) stock closed at a price of $0.05.

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Kalytera Therapeutics (KLY.V)